Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Asthma
Study Title
- A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Teva Identifier
- ABS-AS-201
ClinicalTrials.gov Identifier
- NCT01058863
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 02/01/2010 - 06/01/2010
Phase
- Phase 2
Study Type
Interventional
